These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35294538)

  • 1. Association of the Interaction Between Familial Hypercholesterolemia Variants and Adherence to a Healthy Lifestyle With Risk of Coronary Artery Disease.
    Fahed AC; Wang M; Patel AP; Ajufo E; Maamari DJ; Aragam KG; Brockman DG; Vosburg T; Ellinor PT; Ng K; Khera AV
    JAMA Netw Open; 2022 Mar; 5(3):e222687. PubMed ID: 35294538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
    Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV
    JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease.
    Berry ASF; Jones LK; Sijbrands EJ; Gidding SS; Oetjens MT
    Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):2058-2067. PubMed ID: 37589137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography.
    Lee WJ; Chuang HN; Chen YM; Liang KW; Tung H; Chen JP; Lee IT; Wang JS; Lin CH; Lin HJ; Sheu WH; Lee WL; Hsiao TH
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.
    Khera AV; Won HH; Peloso GM; O'Dushlaine C; Liu D; Stitziel NO; Natarajan P; Nomura A; Emdin CA; Gupta N; Borecki IB; Asselta R; Duga S; Merlini PA; Correa A; Kessler T; Wilson JG; Bown MJ; Hall AS; Braund PS; Carey DJ; Murray MF; Kirchner HL; Leader JB; Lavage DR; Manus JN; Hartzel DN; Samani NJ; Schunkert H; Marrugat J; Elosua R; McPherson R; Farrall M; Watkins H; Lander ES; Rader DJ; Danesh J; Ardissino D; Gabriel S; Willer C; Abecasis GR; Saleheen D; Dewey FE; Kathiresan S;
    JAMA; 2017 Mar; 317(9):937-946. PubMed ID: 28267856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Healthy Lifestyle in Patients With Familial Hypercholesterolemia.
    Tada H; Kojima N; Yamagami K; Nomura A; Nohara A; Usui S; Sakata K; Hayashi K; Fujino N; Takamura M; Kawashiri MA
    JACC Asia; 2023 Feb; 3(1):152-160. PubMed ID: 36873758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic Risk Score for Low-Density Lipoprotein Cholesterol Is Associated With Risk of Ischemic Heart Disease and Enriches for Individuals With Familial Hypercholesterolemia.
    Wu H; Forgetta V; Zhou S; Bhatnagar SR; Paré G; Richards JB
    Circ Genom Precis Med; 2021 Feb; 14(1):e003106. PubMed ID: 33440130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia.
    Reeskamp LF; Volta A; Zuurbier L; Defesche JC; Hovingh GK; Grefhorst A
    J Clin Lipidol; 2020; 14(2):207-217.e7. PubMed ID: 32088153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of FH-Causing Variants and Impact on LDL-C Concentration in European, South Asian, and African Ancestry Groups of the UK Biobank-Brief Report.
    Gratton J; Humphries SE; Futema M
    Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):1737-1742. PubMed ID: 37409534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle factors, genetic susceptibility to obesity and their interactions on coronary artery disease risk: A cohort study in the UK Biobank.
    Choi J; Wen W; Jia G; Tao R; Long J; Shu XO; Zheng W
    Prev Med; 2024 Mar; 180():107886. PubMed ID: 38316272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between lifestyle habits and cardiovascular risk factors in familial hypercholesterolemia.
    Dessureault L; Roy G; Couture P; Gangloff A; Guasch-Ferré M; Pérusse L; Tremblay A; Drouin-Chartier JP
    Nutr Metab Cardiovasc Dis; 2023 Oct; 33(10):2044-2052. PubMed ID: 37543519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic Background Modifies Risk of Coronary Artery Disease Among Individuals With Heterozygous Familial Hypercholesterolemia.
    Reeskamp LF; Shim I; Dron JS; Ibrahim S; Tromp TR; Fahed AC; Patel AP; Hutten BA; Stroes ESG; Hovingh GK; Khera AV
    JACC Adv; 2023 Nov; 2(9):100662. PubMed ID: 38938725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A favorable lifestyle lowers the risk of coronary artery disease consistently across strata of non-modifiable risk factors in a population-based cohort.
    Dimovski K; Orho-Melander M; Drake I
    BMC Public Health; 2019 Nov; 19(1):1575. PubMed ID: 31775698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia.
    Paquette M; Dufour R; Baass A
    J Clin Lipidol; 2018; 12(4):966-971. PubMed ID: 29784573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia.
    Tromp TR; Cupido AJ; Reeskamp LF; Stroes ESG; Hovingh GK; Defesche JC; Schmidt AF; Zuurbier L
    Atherosclerosis; 2022 Jan; 340():61-67. PubMed ID: 34774301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.
    Benn M; Watts GF; Tybjaerg-Hansen A; Nordestgaard BG
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3956-64. PubMed ID: 22893714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study.
    Said MA; Verweij N; van der Harst P
    JAMA Cardiol; 2018 Aug; 3(8):693-702. PubMed ID: 29955826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease.
    Khera AV; Emdin CA; Drake I; Natarajan P; Bick AG; Cook NR; Chasman DI; Baber U; Mehran R; Rader DJ; Fuster V; Boerwinkle E; Melander O; Orho-Melander M; Ridker PM; Kathiresan S
    N Engl J Med; 2016 Dec; 375(24):2349-2358. PubMed ID: 27959714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Nongenetic Factors With Breast Cancer Risk in Genetically Predisposed Groups of Women in the UK Biobank Cohort.
    Al Ajmi K; Lophatananon A; Mekli K; Ollier W; Muir KR
    JAMA Netw Open; 2020 Apr; 3(4):e203760. PubMed ID: 32329772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.